Stay updated on AZD4785 Phase I Dose-Escalation Clinical Trial

Sign up to get notified when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AZD4785 Phase I Dose-Escalation Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record for AZD4785 is displayed in place of the 403 error screen, showing the study details and related information.
    Difference
    47%
    Check dated 2026-11-09T13:48:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T15:47:16.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error for the study record.
    Difference
    1%
    Check dated 2026-10-26T14:57:37.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:45:23.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:50:48.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error and minimal header elements, instead of displaying the full study record content.
    Difference
    18%
    Check dated 2026-09-21T20:34:44.000Z thumbnail image

Stay in the know with updates to AZD4785 Phase I Dose-Escalation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.